[1]君安医学细胞平台专家委员会,白求恩精神研究会检验医学分会细胞检验诊断与推广学组委员会.腹膜透析液细胞形态学检验中国专家共识（2025）[J].现代检验医学杂志,2026,41(03):7-12.[doi:10.3969/j.issn.1671-7414.2026.03.002]
　Expert Committee of Junan Medical Cytology Platform,Cell Diagnostics and Promotion Group,Branch of Laboratory Medicine,et al.Chinese Expert Consensus on Cytomorphological Examination of Peritoneal Dialysis Fluid(2025)[J].Journal of Modern Laboratory Medicine,2026,41(03):7-12.[doi:10.3969/j.issn.1671-7414.2026.03.002]
点击复制

腹膜透析液细胞形态学检验中国专家共识（2025）()

《现代检验医学杂志》[ISSN:/CN:]

卷:
第41卷
期数:
2026年03期
页码:
7-12
栏目:
专家共识
出版日期:
2026-05-13

文章信息/Info

Title:
Chinese Expert Consensus on Cytomorphological Examination of Peritoneal Dialysis Fluid(2025)
文章编号:
1671-7414（2026）03-007-06
作者:
君安医学细胞平台专家委员会，白求恩精神研究会检验医学分会细胞检验诊断与推广学组委员会
Author(s):
Expert Committee of Jun’an Medical Cytology Platform，Cell Diagnostics and Promotion Group, Branch of Laboratory Medicine, Bethune Spirit Research Association
关键词:
腹膜透析液; 细胞形态学检验; 专家共识
分类号:
R446.19
DOI:
10.3969/j.issn.1671-7414.2026.03.002
文献标志码:
A
摘要:
腹膜透析液细胞形态学检查是诊断腹膜透析相关并发症（如腹膜炎）的关键检测技术，亦可用于鉴别诊断腹腔出血、穿孔以及肿瘤腹膜转移等疾病。由于腹膜透析液在标本来源和细胞特性与腹腔积液存在显著差异，且该领域长期以来缺乏统一的技术标准，严重制约其在临床的推广应用。因此，亟须制定针对腹膜透析液细胞形态学检验技术规范。本共识系统阐述腹膜透析液细胞学检验的目的、标本留取、操作流程、报告模式及临床意义，旨在推动该技术的标准化与规范化，为相关疾病的明确诊治提供可靠依据。
Abstract:
Cytological examination of peritoneal dialysis fluid is a key diagnostic technique for identifying peritoneal dialysis-related complications (such as peritonitis) and can also be used for the differential diagnosis of diseases such as intraperitoneal hemorrhage, perforation, and peritoneal metastasis of tumors. However, due to significant differences in sample sources and cellular characteristics between peritoneal dialysis fluid and ascites, and the long-term lack of unified technical standards in this field, its clinical application and promotion have been severely limited. Therefore, it is urgent to establish technical specifications for cytological examination of peritoneal dialysis fluid. This consensus systematically outlines the objectives, specimen collection, operational procedures, reporting formats, and clinical significance of peritoneal dialysis fluid cytology, aiming to promote the standardization and normalization of this technology and provide a reliable basis for the accurate diagnosis and treatment of related diseases.

参考文献/References:

[1] 邓秋, 杨陈, 安宁. 腹膜透析相关性腹膜炎的临床治疗进展[J]. 临床肾脏病杂志, 2024, 24(10): 865-869. DENG Q, YANG C, AN N. Therapeutic advances of peritoneal dialysis-associated peritonitis[J]. Journal of Clinical Nephrology, 2024, 24(10): 865-869.
[2] VAN DER SLUIS K, VAN SANDICK J W, VOLLE-BERGH M A, et al. Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal me-tastases: tumor-guided cell-free DNA analysis of peri-toneal fluid[J]. Oncogene, 2024, 43(24): 1877-1882.
[3] SCHIETZEL S, RIPPIN WAGNER S J, CALANCA L N. Peritonitis in peritoneal dialysis: when to consider acute pancreatitis? Case report and mini-review[J]. Case Reports in Nephrology and Dialysis, 2024, 14(1): 70-80.
[4] LI P K, CHOW K M, CHO Y, et al. ISPD peritonitis guideline recommendations: 2022 update on preven-tion and treatment[J]. Peritoneal Dialysis International, 2022, 42(2): 110-153.
[5] 中国腹膜透析相关感染防治专家组. 腹膜透析相关感染的防治指南[J]. 中华肾脏病杂志, 2018, 34(2): 139-148. Chinese Expert Group for Prevention and Treatment of Peritoneal Dialysis-Related Infection. Prevention and treatment guideline for peritoneal dialysis-related infection [J]. Chinese Journal of Nephrology, 2018, 34(2): 139-148.
[6] 中华人民共和国国家卫生健康委员会. WS/T 662-2020: 临床体液检验技术要求[S]. 北京: 中国标准出版社, 2020. National Health Commission of the People’s Republic of Chi-na. WS/T 662-2020: Technical requirements for clinical body fluid examination[S]. Beijing: China Standards Press, 2020.
[7] 王冲, 朱捷, 杨烁, 等. 全自动血液分析仪用于浆膜腔积液常规细胞计数可行性研究[J]. 检验医学, 2022, 37(6): 551-556. WANG C, ZHU J, YANG S, et al. Feasibility study of auto-mated hematology analyzer on routine cell counts of serous cavity effusion [J]. Laboratory Medicine, 2022, 37(6): 551-556.
[8] 君安医学细胞平台专家委员会. 脑脊液细胞形态学检验中国专家共识(2023)[J]. 现代检验医学杂志, 2023, 38(3): 1-5. Expert Committee of J.EDU Medical Cell Platform Solicit-ing Contributions. Consensus of Chinese experts on cellular morphological examination of cerebrospinal fluid(2023) [J]. Journal of Modern Laboratory Medicine, 2023, 38(3): 1-5.
[9] 君安医学细胞平台专家委员会. 浆膜腔积液细胞形态学检验中国专家共识(2023)[J]. 现代检验医学杂志, 2023, 38(3): 6-10. Expert Committee of J.EDU Medical Cell Platform Solicit-ing Contributions. Consensus of Chinese experts on cellular morphological examination of serous effusion(2023)[J]. Journal of Modern Laboratory Medicine, 2023, 38(3): 6-10.
[10] 张纪云, 龚道元. 临床检验基础[M]. 5版. 北京: 人民卫生出版社, 2020. ZHANG J Y, GONG D Y. Basic clinical laboratory medicine[M]. 5th ed. Beijing: People’s Medical Pub-lishing House, 2020.
[11] 中华人民共和国国务院. 医疗废物管理条例[Z]. 2023 (2011修订). State Council of the People’s Republic of China. Regulations on the administration of medical wastes[Z]. 2003 (Revised 2011).
[12] ZHANG J H, CHEN Y X, CHEN T F, et al. Single-cell transcriptomics provides new insights into the role of fibroblasts during peritoneal fibrosis[J]. Clinical and Translational Medicine, 2021, 11(3): e321.
[13] TAKAHASHI K, KURASHINA K, YAMAGUCHI H, et al. Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric can-cer[J]. Frontiers in Immunology, 2022, 13: 969468.
[14] HUANG Q, SUN Y X, PENG L, et al. Extracellular vesicle-packaged ILK from mesothelial cells promotes fibroblast activation in peritoneal fibrosis[J]. Journal of Extracellular Vesicles, 2023, 12(7): e12334.
[15] LI S T, ZHUANG Y Y, JI Y, et al. BRG1 accelerates mesothelial cell senescence and peritoneal fibrosis by inhibiting mitophagy through repression of OXR1[J]. Free Radical Biology & Medicine, 2024, 214: 54-68.
[16] MEHROTRA R, WILLIAMSON D E, BETTS C R, et al. A prospective clinical study to evaluate the ability of the CloudCath system to detect peritonitis during in-home peritoneal dialysis (CATCH)[J]. Kidney International Re-ports, 2024, 9(4): 929-940.
[17] SU H Y, ZOU R, SU J Q, et al. Sterile inflammation of peri-toneal membrane caused by peritoneal dialysis: focus on the communication between immune cells and peritoneal stroma[J]. Frontiers in Immunology, 2024, 15: 1387292.
[18] SZEBENI B, VERES-SZ?KELY A, PAP D, et al. Ex-tracellular vesicles of patients on peritoneal dialysis inhibit the TGF-β- and PDGF-B-mediated fibrotic processes[J]. Cells, 2024, 13(7): 605.
[19] CHENG X B J, BARGMAN J. Complications of peri-toneal dialysis part II: nonmechanical complications[J]. Clinical Journal of the American Society of Nephrolo-gy, 2024, 19(6): 791-799.
[20] SUTHERLAND T E, SHAW T N, LENNON R, et al. On-going exposure to peritoneal dialysis fluid alters resident peritoneal macrophage phenotype and activation propensi-ty[J]. Frontiers in Immunology, 2021, 12: 715209.
[21] SUN Y X, HUANG Q, SUN J, et al. Mucosal-associat-ed invariant T (MAIT) cell-mediated immune mecha-nisms of peritoneal dialysis-induced peritoneal fibrosis and therapeutic targeting[J]. Journal of the American Society of Nephrology, 2025, 36(6): 1072-1087.
[22] CRANE C, CUNARD R A, SWEISS N, et al. Anaphy-laxis from ethylene oxide-sterilized dialysis tubing and needles: a case report[J]. American Journal of Kidney Diseases, 2023, 82(2): 243-246.
[23] ZHANG Q Y, XIA Y Y, ZHANG M, et al. Peritoneal dialysis-related eosinophilic peritonitis: a case report and review of the literature[J]. BMC Nephrol, 2023, 24(1): 10.
[24] YANG C Y, CHANG P Y, CHEN J Y, et al. Adipose-derived mesenchymal stem cells attenuate dialysis-induced peritoneal fibrosis by modulating macrophage polarization via interleu-kin-6[J]. Stem Cell Research & Therapy, 2021, 12(1): 193.
[25] YU F, CHEN J, WANG X Y, et al. Metabolic reprogram-ming of peritoneal mesothelial cells in peritoneal dialy-sis-associated fibrosis: therapeutic targets and strategies[J]. Cell Communication and Signaling, 2025, 23(1): 114.
[26] Ramil-Gómez O, López-Pardo M, Fernández-Rodríguez J A, et al. Involvement of mitochondrial dysfunction in the inflam-matory response in human mesothelial cells from peritoneal dialysis e?uent[J]. Antioxidants (Basel), 2022, 11(11): 2184.
[27] BAI L, NI B, SHEN X Y, et al. Effectiveness of circulating tumor cells and circulating tumor DNA in peritoneal lavage fluid for predicting metachronous peritoneal metastasis of gastric cancer[J]. Translational Research, 2025, 283: 13-21.
[28] MEI S S, CHEN X, WANG K, et al. Tumor microen-vironment in ovarian cancer peritoneal metastasis[J]. Cancer Cell International, 2023, 23(1): 11.
[29] WU X J, WU S R, SHAN J P, et al. Resolution of peritoneal dialysis-associated peritonitis from Weissella confusa com-bined with gastric hookworm disease: a case report and litera-ture review[J]. Seminars in Dialysis, 2024, 37(5): 404-407.

相似文献/References:

[1]吴友伟,石红,刘万静,等.腹膜透析液微生物培养病原学分析[J].现代检验医学杂志,2016,31(06):92.[doi:10.3969/j.issn.1671-7414.2016.06.026]
　WU You-wei,SHI Hong,LIU Wan-jing,et al.Bacteria Distribution and Drug Resistance Analysis of Peritoneal Dialysis Fluid[J].Journal of Modern Laboratory Medicine,2016,31(03):92.[doi:10.3969/j.issn.1671-7414.2016.06.026]
[2]君安医学细胞平台专家委员会,白求恩精神研究会检验医学分会细胞检验诊断与推广学组委员会.胸腹部术后引流液细胞形态学检验中国专家共识（2025）[J].现代检验医学杂志,2026,41(03):1.[doi:10.3969/j.issn.1671-7414.2026.03.001]
　Expert Committee of Junan Medical Cytology Platform,Cell Diagnostics and Promotion Group,Branch of Laboratory Medicine,et al.Chinese Expert Consensus on Cytomorphological Examination of Postoperative Thoracoabdominal Drainage Fluid(2025)[J].Journal of Modern Laboratory Medicine,2026,41(03):1.[doi:10.3969/j.issn.1671-7414.2026.03.001]

备注/Memo

备注/Memo:
通讯作者： 吴茅（1961-），男，学士，主任技师，从事骨髓、胸腹腔积液等体液细胞检验与诊断，E-mail：wumao3000@163.com。
李相磊（1980-），男，学士，副主任技师，从事血液、体液及骨髓细胞学检验，E-mail：lixianglei1980@163.com。
更新日期/Last Update: 2026-05-15